Академический Документы
Профессиональный Документы
Культура Документы
com
MAGLinhibitorandFAAHInhibitor: JW-642&OL-135&PF-750............................................... 1
I.JW 642 basic Characters:.......................................................................................1
1. JW-642 Review.................................................................................................... 2
2. Biological Activity–CAS: 1416133-89-5............................................................... 3
3. OL-135 Review.....................................................................................................4
4. Biological Activity–CAS: 681135-77-3................................................................. 5
5. PF-750 Review..................................................................................................... 5
6. Biological Activity–CAS: 959151-50-9................................................................. 6
7. JZL-184 Review.................................................................................................... 7
8. Biological Activity–CAS: 1101854-58-3............................................................... 8
9. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group8
10. Guide on buy JW-642 MAGL inhibitor step by step.......................................... 9
Name: JW 642
CAS: 1416133-89-5
Molecular Formula: C21H20F6N2O3
Molecular Weight: 462.4
Melt Point:
Storage Temp: at -20°C 3 years Powder
Color: White solid
1. JW-642 Review
3. OL-135 Review
OL-135 is a CNS penetrant, highly potent and selective reversible inhibitor of FAAH.
OL-135 exhibits analgesic pharmacology in various animal models without the motor
impairment associated with direct CB1 agonism.FAAH Inhibitor OL-135 disrupts the
acquisition, but not consolidation, of contextual fear conditioning.Auditory fear
conditioning and shock reactivity remain unaffected.Together, these data suggest a
specific role for endocannabinoids in a subset of fear conditioning paradigms.
OL-135 is a CNS penetrant, highly potent and selective reversible inhibitor of FAAH
devoid of CB1, CB2 and μ and δ opioid receptors activities that increases the
analgesic and hypothermic activity of anandamide
5. PF-750 Review
Fatty acid amide hydrolase (FAAH) is the enzyme responsible for hydrolysis and
inactivation of fatty acid amides including anandamide and oleamide. PF-750 is a
potent, time-dependent, irreversible FAAH inhibitor with IC50 values of 0.6 and
0.016 µM when preincubated with recombinant human FAAH for 5 and 60 minutes,
respectively.1 Activity-based profiling of various human and murine tissue proteome
samples revealed that PF-750 is highly selective for FAAH relative to other serine
hydrolases, showing no discernable off-site activity up to 500 µM.
PF-750 is a potent, time-dependent, irreversible FAAH inhibitor with IC50 values 0.6
and 0.016 μM when preincubated with recombinant human FAAH for 5 and 60
minutes, respectively. Fatty acid amide hydrolase (FAAH) is the enzyme responsible
for hydrolysis and inactivation of fatty acid amides including anandamide and
oleamide. Activity-based profiling of various human and murine tissue proteome
samples revealed that PF-750 is highly selective for FAAH relative to other serine
hydrolases, showing no discernable off-site activity up to 500 μM. PF-750 shows
10-fold better potency than URB597 (Sigma# U4133) after 30 min preincubation.
PF-750 is highly selective on FAAH. Even at as high as 500 μM, it had no interactions
with many tested enzymes, but URB597 and other known FAAH inhibitors did not
perform well at low concentraction (100 μM).
7. JZL-184 Review
JZL-184 selectively inhibits MAGL, the enzyme predominantly responsible for the
degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG). Anandamide
and 2-AG are the two endogenous endocannabinoids that activate the cannabinoid
receptors CB1 and CB2. Anandamide is predominantly metabolized by fatty acid
amide hydrolase (FAAH), whereas monoacylglycerol lipase (MAGL) is thought to be
the enzyme primarily responsible for the degradation of 2-AG. It is difficult to
separate the activities of the two because most currently available inhibitors of
MAGL are not selective, and also inhibit FAAH or other enzymes. JZL-184 is the first
selective inhibitor of MAGL with nanomolar portency and over 200-fold selectivity
for MAGL vs FAAH. When administered to mice, JZL-184 increased levels of
2-arachidonoylglycerol in the brain by about 8-fold, with no effect on levels of
anandamide.